A Novel Serum-Based Bioassay for Quantification of Cancer-Associated Transformation Activity: A Case-Control and

Aye Aye Khine1, Hsuan-Shun Huang1, Pao-Chu Chen2

  • 1Center for Prevention and Therapy of Gynecological Cancers, Department of Research, Hualien Tzu Chi Hospital, Hualien 97004, Taiwan.

PubMed
Summary

A novel biotest using human fallopian tube cells detects ovarian cancer by measuring anchorage-independent growth (AIG) in response to serum factors. This assay shows high accuracy and potential for early cancer detection.

Related Concept Videos